Botulinum toxin: A potential alternative to current treatment of neurogenic and idiopathic urinary incontinence due to detrusor overactivity

International Journal of Gynecology and Obstetrics

Volumn 95, Issue 3, 2006, Pages 305-311

  Casanova, N ^a   McGuire, E ^a   Fenner, D E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Botulinum toxin; Detrusor overactivity; Neurogenic bladder

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

ARTICLE; BLADDER CAPACITY; COST BENEFIT ANALYSIS; CYSTOMETRY; DILUTION; DRUG EFFICACY; FOLLOW UP; HUMAN; INJECTION SITE; MEDLINE; NEUROGENIC BLADDER; PRIORITY JOURNAL; QUALITY OF LIFE; REFLEX; RESIDUAL URINE; TREATMENT OUTCOME; URINARY URGENCY; URINE INCONTINENCE; URINE RETENTION; URODYNAMICS;

EID: 33750817630     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2006.08.014     Document Type: Article

References (16)

1. Frenkl T.L., and Rackley R.R. Injectable neuromodulatory agents: botulinum toxin therapy. Urol Clin North Am 32 (2005) 89-99
2. Bullock T.L., Klutke C.G., and Klutke J.J. Botulinum toxin in the treatment of neurogenic and idiopathic urinary incontinence. Female Patient 31 (2006) 14-24
3. Reitz A., Stohrer M., and Kramer G. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45 (2004) 510-515
4. The standardization of terminology in lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society. Urology 61 (2003) 37-49
5. Schurch B., Stohrer M., and Kramer G. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164 (2000) 692-697
6. Bagi P., and Biering-Sorensen F. Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions. Scand J Urol Nephrol 38 (2004) 495-498
7. Klaphajone J., Kitisomprayoonkul W., and Sriplakit S. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions. Arch Phys Med Rehabil 86 (2005) 2114-2118
8. Schurch B., DeSeze M., and Denys P. Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a singe treatment, randomized, placebo controlled 6 mo study. J Urol 174 (2005) 196-200
9. Schmid D.M., Sauermann P., Werner M., Schuessler B., Blick N., Muentener M., et al. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176 (2006) 177-185
10. Werner M., Schmid D., and Schussler B. Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study. AJOG 192 (2005) 1735-1740
11. Kuo H. Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics. Urology 66 (2005) 94-98
12. Schulte-Baukloh H., Weiss C., and Stolze T. Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction. Urology 66 (2005) 81-87
13. Popat R., Apostolidis A., and Kalsi V. A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 174 (2005) 984-989
14. Dykstra D., Enriquez A., and Valley M. Treatment of overactive bladder with botulinum toxin type B: a pilot study. Int Urogynecol J 14 6 (2003) 424-426
15. Ghei M., Maraj B.H., and Miller R. Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial. J Urol 174 (2005) 1873-1877
16. Reitz A., and Schurch B. Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity. J Urol 171 (2004) 804-805